{
  "cik": 1472012,
  "cik_padded": "0001472012",
  "entityName": "Immunome Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-088172",
      "filed": "2026-03-03",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 9685000.0,
        "cash": 653482000.0,
        "eps_diluted": -2.43,
        "free_cash_flow": -200604000.0,
        "net_income": -212394000.0,
        "operating_cash_flow": -190919000.0,
        "operating_income": -224113000.0,
        "revenue": 6941000.0,
        "stockholders_equity": 634343000.0,
        "total_assets": 683188000.0,
        "total_liabilities": 48845000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.07700092851974405,
        "revenue_growth_yoy": -0.23227519079747816,
        "roa_avg2y": -0.4600115439302859,
        "roa_period_end": -0.31088660807859625,
        "roe_avg2y": -0.5208875939904942,
        "roe_period_end": -0.3348251655650019
      }
    },
    {
      "accn": "0001193125-26-088172",
      "filed": "2026-03-03",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7173000.0,
        "cash": 143351000.0,
        "eps_diluted": -5.0,
        "free_cash_flow": -117967000.0,
        "net_income": -292963000.0,
        "operating_cash_flow": -110794000.0,
        "operating_income": -305800000.0,
        "revenue": 9041000.0,
        "stockholders_equity": 181165000.0,
        "total_assets": 240241000.0,
        "total_liabilities": 59076000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3260894764441255,
        "revenue_growth_yoy": -0.355043515480097,
        "roa_avg2y": -1.5070849655718772,
        "roa_period_end": -1.2194546309747296,
        "roe_avg2y": -1.9462941002567706,
        "roe_period_end": -1.6171059531366432
      }
    },
    {
      "accn": "0001558370-25-003302",
      "filed": "2026-03-03",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 831000.0,
        "cash": 98679000.0,
        "eps_diluted": -5.38,
        "free_cash_flow": -8399000.0,
        "net_income": -106806000.0,
        "operating_cash_flow": -7568000.0,
        "operating_income": -109530000.0,
        "revenue": 14018000.0,
        "stockholders_equity": 119882000.0,
        "total_assets": 148540000.0,
        "total_liabilities": 28658000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.23905173420530187,
        "roa_avg2y": -1.2377133718841622,
        "roa_period_end": -0.7190386427898209,
        "roe_avg2y": -1.5645219174570624,
        "roe_period_end": -0.8909260773093542
      }
    },
    {
      "accn": "0001558370-25-003302",
      "filed": "2025-03-19",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 248000.0,
        "cash": 20323000.0,
        "eps_diluted": -3.09,
        "free_cash_flow": -28938000.0,
        "net_income": -36896000.0,
        "operating_cash_flow": -28690000.0,
        "operating_income": -36901000.0,
        "stockholders_equity": 16653000.0,
        "total_assets": 24046000.0,
        "total_liabilities": 7393000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4439440341079685,
        "roa_avg2y": -0.9002208097985873,
        "roa_period_end": -1.5343924145388008,
        "roe_avg2y": -1.13809802893365,
        "roe_period_end": -2.2155767729538223
      }
    },
    {
      "accn": "0001558370-24-004247",
      "filed": "2024-03-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 79000.0,
        "cash": 49229000.0,
        "eps_diluted": -2.14,
        "free_cash_flow": -18305000.0,
        "net_income": -24711000.0,
        "operating_cash_flow": -18226000.0,
        "operating_income": -25204000.0,
        "stockholders_equity": 48185000.0,
        "total_assets": 57925000.0,
        "total_liabilities": 9740000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2021375946871433,
        "roa_avg2y": -0.4824011713030747,
        "roa_period_end": -0.42660336642209756,
        "roe_avg2y": -0.5520160839941919,
        "roe_period_end": -0.5128359447960984
      }
    },
    {
      "accn": "0001558370-23-003964",
      "filed": "2023-03-16",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 586000.0,
        "cash": 39766000.0,
        "eps_diluted": -5.26,
        "free_cash_flow": -12720000.0,
        "net_income": -17837000.0,
        "operating_cash_flow": -12134000.0,
        "operating_income": -12261000.0,
        "stockholders_equity": 41345000.0,
        "total_assets": 44525000.0,
        "total_liabilities": 3180000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.0769137743378885,
        "roa_avg2y": -0.7194514470101845,
        "roa_period_end": -0.40060640089837174,
        "roe_avg2y": -6.242169728783902,
        "roe_period_end": -0.43141855121538275
      }
    },
    {
      "accn": "0001558370-22-004420",
      "filed": "2022-03-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 233000.0,
        "cash": 2543000.0,
        "free_cash_flow": -9833000.0,
        "net_income": -10444000.0,
        "operating_cash_flow": -9600000.0,
        "operating_income": -10348000.0,
        "stockholders_equity": -35630000.0,
        "total_assets": 5060000.0,
        "total_liabilities": 1796000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.34335497657598424
      }
    },
    {
      "accn": "0001558370-21-003493",
      "filed": "2021-03-25",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -25205000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-088172",
    "filed": "2026-03-03",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001472012.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001472012.json"
  },
  "ticker": "IMNM"
}